COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management
The outbreak of the novel coronavirus infectious disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has rapidly spread around the world. Increasing evidence has suggested that patients with COVID-19 may present neurological symptoms, and cerebrovascular diseases are one of the most frequent como...
Main Authors: | Zilan Wang, Yanbo Yang, Xiaolong Liang, Bixi Gao, Meirong Liu, Wen Li, Zhouqing Chen, Zhong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2020.571996/full |
Similar Items
-
ISCHEMIC STROKE AND INTRACEREBRAL HEMORRHAGE IN PATIENTS WITH COVID-19
by: Hamid BEHZADNIA, et al.
Published: (2020-09-01) -
Lipid Profile in Patients with Ischemic and Hemorrhagic Stroke
by: Mohammad Saadatnia, et al.
Published: (2011-04-01) -
A Comparative Study on the Effect of Citicoline on Acute Ischemic and Hemorrhagic Stroke
by: Shahir Mazaheri, et al.
Published: (2018-06-01) -
Differences in Body Composition among Patientsafter Hemorrhagic and Ischemic Stroke
by: Jacek Wilczyński, et al.
Published: (2020-06-01) -
Lipid Paradox in Statin-Naïve Acute Ischemic Stroke But Not Hemorrhagic Stroke
by: Kai-Hung Cheng, et al.
Published: (2018-08-01)